Publications by authors named "Maureen May"

Claim this Profile
D
Detection rates of multigene panel and exome testing in patients with previous negative BRCA1/2 results.
Jewel L Wasson, Trinity N Sprague, Darcy L Thull, Maureen May, Kathleen E Vitale

Fam Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
W Gordon Frankle, Brigitte Robertson, Gary Maier, Jennifer Paris, Deanna Asmonga, Maureen May

Synapse· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortical Dopamine Transmission as Measured with the [11C]FLB 457 - Amphetamine PET Imaging Paradigm Is Not Influenced by COMT Genotype.
Rajesh Narendran, Divya Tumuluru, Maureen A May, Kodavali V Chowdari, Michael L Himes

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing patients at genetic risk of breast cancer.
Holly J Pederson, Shilpa A Padia, Maureen May, Stephen Grobmyer

Cleve Clin J Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of olfactory deficits as part of the phenotypic spectrum of nonsyndromic orofacial clefting.
Maureen A May, Carla A Sanchez, Frederic W B Deleyiannis, Mary L Marazita, Seth M Weinberg

J Craniofac Surg· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.
Rajesh Narendran, Brian J Lopresti, Diana Martinez, Neale Scott Mason, Michael Himes, Maureen A May

Am J Psychiatry· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
Rajesh Narendran, Diana Martinez, Neale Scott Mason, Brian J Lopresti, Michael L Himes, Maureen A May

Synapse· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
Rajesh Narendran, N Scott Mason, Chi-Min Chen, Michael Himes, Patrick Keating, Maureen A May

Synapse· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
Rajesh Narendran, N Scott Mason, Maureen A May, Chi-Min Chen, Steve Kendro

Synapse· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
W Gordon Frankle, N Scott Mason, Eugenii A Rabiner, Khanum Ridler, Maureen A May

Synapse· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
Rajesh Narendran, N Scott Mason, Charles M Laymon, Brian J Lopresti, Natalie D Velasquez, Maureen A May

J Pharmacol Exp Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis